Clinical trials
Suspended Phase 2 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
| 2011 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Suspended | 30 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2 |
| Fudan University | 2 |
| Jiangsu HengRui Medicine Co., Ltd. | 2 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2 |
| Tianjin Medical University Cancer Institute and Hospital | 2 |
| Zhejiang Cancer Hospital | 2 |
| Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 1 |
| Beijing Biostar Pharmaceuticals Co., Ltd. | 1 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 1 |
| Guangzhou Women and Children's Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Ischemic Stroke | 2 |
| Autism Spectrum Disorder | 1 |
| Breast Neoplasms | 1 |
| Carotid Stenosis | 1 |
| Cholangiocarcinoma | 1 |
| Congenital Abnormalities | 1 |
| Drug-Related Side Effects and Adverse Reactions | 1 |
| Esophageal Squamous Cell Carcinoma | 1 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.